Hormone therapy includes tamoxifen and aromatase inhibitors.

激素治疗包括三苯氧胺和芳香酶抑制剂.

互联网

Under age 40 years with abnormal uterine bleeding and risk factors ( eg, chronic anovulation, obesity, tamoxifen ).

年龄小于40,有异常子宫出血及高危因素 ( 如:慢性无排卵 、 肥胖 、 使用三苯氧胺 ).

互联网

Tamoxifen improves bone density in postmenopausal women, and there is some evidence of fracture reduction.

三苯氧胺改善绝经后妇女的骨密度, 并可减少骨折的发生.

互联网

Despite, tamoxifen and another drug, raloxifene, remain an extensively used and popular treatment.

虽然存在这些副作用, 三苯氧胺和另一种同类药物-雷洛西芬已经被广泛用于乳腺癌的治疗.

互联网

Unlike tamoxifen, aromatase inhibitors do not cause menopausal symptoms, but they may increase risk of osteoporosis.

与三苯氧胺不同的是, 芳香抑制剂不会引起绝经期症状, 但可增加骨质疏松症危险.

互联网